Skip to main content
. 2021 Jun 13;10(12):2608. doi: 10.3390/jcm10122608

Table 3.

Association between potential predictive factors and intensive care unit admission for COVID-19 in the general population cohort.

Intensive Care Unit Admissions Sex- and Age-Adjusted Analysis Fully Adjusted Analysis *
n Cases per 100,000 RR 95% CI p Value RR 95% CI p Value
Total 246 38
Sex
Female 92 28 1 1
Male 154 48 1.79 1.38–2.31 <0.001 2.02 1.53–2.66 <0.001
Age, years
0–14 1 1 0.02 0.00–0.11 <0.001 0.02 0–0.14 <0.001
15–29 2 2 0.03 0.01–0.13 <0.001 0.03 0.01–0.11 <0.001
30–49 30 16 0.26 0.17–0.40 <0.001 0.23 0.15–0.37 <0.001
50–59 59 63 1 1
60–69 72 101 1.62 1.15–2.29 0.006 1.73 1.21–2.46 0.003
70–79 68 127 2.07 1.46–2.93 <0.001 2.21 1.49–3.29 <0.001
80+ 14 37 0.64 0.36–1.15 0.139 0.72 0.37–1.38 0.320
Nursing home resident 4 81 1.47 0.54–4.01 0.455 2.07 0.75–5.74 0.161
Healthcare worker 4 36 1.10 0.41–2.99 0.850 1.55 0.56–4.23 0.397
Place of birth
Spain 175 32 1 1
Europe 7 27 1.31 0.61–2.80 0.491 1.24 0.57–2.67 0.588
Latin America 55 107 6.73 4.88–9.30 <0.001 6.15 4.34–8.72 <0.001
North Africa 7 44 2.84 1.32–6.10 0.008 2.88 1.30–6.36 0.009
Sub-Saharan Africa 2 28 1.67 0.41–6.80 0.472 1.38 0.34–5.70 0.654
Other 0 0 NE NE
Place of residence
>50,000 inhabitants 84 41 1.55 1.11–2.17 0.010 1.39 0.99–1.95 0.061
5000–50,000 inhabitants 104 47 1.97 1.43–2.71 <0.001 1.80 1.30–2.50 <0.001
<5000 inhabitants 58 27 1 1
Income level
Very low 17 61 2.79 1.66–4.70 <0.001 1.49 0.85–2.61 0.162
Low 131 37 1.21 0.93–1.59 0.158 0.96 0.72–1.27 0.755
Middle 96 37 1 1
High 2 44 1.08 0.27–4.38 0.917 1.15 0.28–4.67 0.846
Smoking status
Never smoker 30 37 1 1
Current smoker 67 63 0.50 0.32–0.77 0.002 0.57 0.36–0.89 0.014
Former smoker 27 112 0.97 0.62–1.53 0.895 1.01 0.64–1.60 0.961
Unknown 122 28 0.72 0.52–0.98 0.037 0.77 0.56–1.05 0.099
Hospitalization in prior year 16 48 0.89 0.54–1.49 0.662 0.84 0.50–1.41 0.516
Immunodeficiency 5 103 1.93 0.80–4.69 0.145 1.66 0.68–4.06 0.267
Diabetes 46 121 1.56 1.11–2.17 0.009 1.21 0.86–1.72 0.276
Cardiovascular disease 33 63 1.00 0.69–1.47 0.988 0.90 0.61–1.33 0.595
COPD 22 80 1.14 0.73–1.78 0.559 1.22 0.78–1.92 0.386
Asthma 23 55 1.94 1.26–2.99 0.003 1.84 1.19–2.83 0.006
Chronic kidney disease 22 114 1.70 1.07–2.68 0.025 1.49 0.94–2.39 0.093
Cerebrovascular disease 7 73 0.89 0.42–1.91 0.774 0.85 0.40–1.83 0.679
Liver cirrhosis 16 133 1.72 1.03–2.86 0.037 1.43 0.85–2.39 0.173
Dementia 0 0 NE NE
Hematological malignancy 1 37 0.52 0.07–3.72 0.516 0.55 0.08–3.91 0.548
Non-hematological cancer 29 75 0.87 0.59–1.30 0.506 0.92 0.61–1.37 0.673
Severe obesity 16 191 3.69 2.22–6.13 <0.001 3.05 1.81–5.14 <0.001
Hypertension 100 103 1.53 1.15–2.03 0.003 1.36 1.01–1.83 0.041
Functional dependence 1 22 0.42 0.06–3.05 0.392 0.52 0.07–3.81 0.520

COPD, chronic obstructive pulmonary diseases; NE, no events; RR, relative risk; CI, confidence interval; *Adjusted for all the variables in the table.